{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:30:34Z","timestamp":1790638234731,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejpb.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T19:16:50Z","timestamp":1469128610000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons"],"prefix":"10.1016","volume":"108","author":[{"given":"Jana","family":"Pardeike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Zarfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Pagitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.07.018_b0005","first-page":"44","article-title":"A three-year study of viable airborne fungi in the North Carolina Zoological Park R.J.R. Nabisco Rocky Coast Alcid Exhibit","volume":"30","author":"Faucette","year":"1999","journal-title":"J. Zoo Wildl. Med."},{"key":"10.1016\/j.ejpb.2016.07.018_b0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1647\/1082-6742(2001)015[0114:ABADIA]2.0.CO;2","article-title":"Aspergillus blepharitis and dermatitis in a peregrine falcon-gyrfalcon hybrid (Falco peregrinus\u00d7Falco rusticolus)","volume":"15","author":"Abrams","year":"2001","journal-title":"J. Avian Med. Surg."},{"key":"10.1016\/j.ejpb.2016.07.018_b0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1647\/1082-6742(2007)21[307:TUOVFT]2.0.CO;2","article-title":"The use of voriconazole for the treatment of aspergillosis in falcons (Falco species)","volume":"21","author":"Di Somma","year":"2007","journal-title":"J. Avian Med. Surg."},{"key":"10.1016\/j.ejpb.2016.07.018_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/AX.2000.4618","article-title":"Overview of aspergillosis: pathogenesis and treatment options","volume":"9","author":"Orosz","year":"2000","journal-title":"Sem. Avian Exot. Pet Med."},{"key":"10.1016\/j.ejpb.2016.07.018_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/AX.2000.4617","article-title":"Aspergillosis in raptors","volume":"9","author":"Joseph","year":"2000","journal-title":"Sem. Avian Exot. Pet Med."},{"key":"10.1016\/j.ejpb.2016.07.018_b0030","unstructured":"Lindena BH, Brunner P, Zarfl HP. Verfahren und Vorrichtung zur Erzeugung eines Nanoaerolsol. In: GmbH MV, editor, Medic Activ Vertriebs GmbH, Germany; 2010."},{"key":"10.1016\/j.ejpb.2016.07.018_b0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","article-title":"20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications","volume":"8","author":"Muller","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejpb.2016.07.018_b0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2003.11.012","article-title":"Investigations on the structure of solid lipid nanoparticles (SLN) an oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy","volume":"95","author":"Jores","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.07.018_b0045","first-page":"539","article-title":"Solid lipid nanoparticles (SLN)\u2013effects of lipid composition on in vitro degradation and in vivo toxicity","volume":"61","author":"Weyhers","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.07.018_b0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(01)00660-3","article-title":"Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages","volume":"221","author":"Scholer","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1023\/A:1012043315093","article-title":"Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant","volume":"14","author":"Muller","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.07.018_b0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpb.2008.09.003","article-title":"Lipid nanoparticles for parenteral delivery of actives","volume":"71","author":"Joshi","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","article-title":"Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejpb.2016.07.018_b0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2010.02.006","article-title":"Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers","volume":"144","author":"Patlolla","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.07.018_b0090","unstructured":"European Pharmacopeia, six ed., 2007."},{"key":"10.1016\/j.ejpb.2016.07.018_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0021-9797(91)90451-D","article-title":"Electrophoretic properties of emulsions for parenteral nutrition determined by laser light scattering and application of the amplitude weighted phase structure function (AWPS)","volume":"143","author":"Stampa","year":"1991","journal-title":"J. Coll. Interf. Sci."},{"key":"10.1016\/j.ejpb.2016.07.018_b0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery I \u2013 production. Characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2016.07.018_b0110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jps.10126","article-title":"Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7","volume":"91","author":"Peeters","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.018_b0115","series-title":"Zetapotential Und Partikelladung in Der Laborpraxis","author":"M\u00fcller","year":"1996"},{"key":"10.1016\/j.ejpb.2016.07.018_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1014276917363","article-title":"Production and characterization of a budesonide nanosuspension for pulmonary administration","volume":"19","author":"Jacobs","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.07.018_b0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersion","volume":"168","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0130","unstructured":"A. zur M\u00fchlen, Feste Lipid Nanopartikel mit Prolongierter Wirkstoffliberation. Herstellung, Langzeitstabilit\u00e4t, Charakterisierung, Freisetzungsverhalten und -mechanismen, in, Freie Universit\u00e4t Berlin, Berlin, 1996."},{"key":"10.1016\/j.ejpb.2016.07.018_b0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.09.008","article-title":"Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release","volume":"383","author":"Kim","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0140","article-title":"Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative","author":"Clift","year":"2010","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2016.07.018_b0145","series-title":"Zell- Und Gewebekultur Einf\u00fchrung in Die Grundlagen Sowie Ausgew\u00e4hlte Methoden Und Anwendungen","author":"Lindl","year":"1994"},{"key":"10.1016\/j.ejpb.2016.07.018_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","article-title":"Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages","volume":"231","author":"Scholer","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0160","first-page":"585","article-title":"Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery","volume":"65","author":"Hu","year":"2010","journal-title":"Pharmazie"},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2016.07.018_b0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08958370903005769","article-title":"Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models","volume":"21","author":"Nassimi","year":"2009","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ejpb.2016.07.018_b0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2010.02.014","article-title":"A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung","volume":"75","author":"Nassimi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.07.018_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-3659(91)90053-G","article-title":"Contemporary approaches in aerosolized drug delivery to the lung","volume":"17","author":"Gupta","year":"1991","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.07.018_b0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jam.2000.13.393","article-title":"Rationale for the choice of an aerosol delivery system","volume":"13","author":"Roche","year":"2000","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ejpb.2016.07.018_b0185","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/08958370050085156","article-title":"Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women","volume":"12","author":"Jaques","year":"2000","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ejpb.2016.07.018_b0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-8977-7-2","article-title":"Deposition and biokinetics of inhaled nanoparticles","volume":"7","author":"Geiser","year":"2010","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.ejpb.2016.07.018_b0195","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1164\/rccm.200602-301OC","article-title":"Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery","volume":"177","author":"Moller","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2016.07.018_b0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1289\/ehp.97105188","article-title":"The avian respiratory system: a unique model for studies of respiratory toxicosis and for monitoring air quality","volume":"105","author":"Brown","year":"1997","journal-title":"Environ. Health Perspect."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:54:35Z","timestamp":1536573275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116303186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":39,"alternative-id":["S0939641116303186"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.018","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}